Literature DB >> 20980482

Escherichia coli K88ac fimbriae expressing heat-labile and heat-stable (STa) toxin epitopes elicit antibodies that neutralize cholera toxin and STa toxin and inhibit adherence of K88ac fimbrial E. coli.

Chengxian Zhang1, Weiping Zhang.   

Abstract

Enterotoxigenic Escherichia coli (ETEC) strains are a major cause of diarrheal disease in humans and animals. Bacterial adhesins and heat-labile (LT) and heat-stable (ST) enterotoxins are the virulence determinants in ETEC diarrhea. It is believed that vaccines inducing anti-adhesin immunity to inhibit bacterial adherence and anti-toxin immunity to eliminate toxin activity would provide broad-spectrum protection against ETEC. In this study, an ETEC fimbrial adhesin was used as a platform to express LT and STa for adhesin-toxin fusion antigens to induce anti-toxin and anti-adhesin immunity. An epitope from the B subunit of LT toxin (LTP1, (8)LCSEYRNTQIYTIN(21)) and an STa toxoid epitope ((5)CCELCCNPQCAGCY(18)) were embedded in the FaeG major subunit of E. coli K88ac fimbriae. Constructed K88ac-toxin chimeric fimbriae were harvested and used for rabbit immunization. Immunized rabbits developed anti-K88ac, anti-LT, and anti-STa antibodies. Moreover, induced antibodies not only inhibited adherence of K88ac fimbrial E. coli to porcine small intestinal enterocytes but also neutralized cholera toxin and STa toxin. Data from this study demonstrated that K88ac fimbriae expressing LT and STa epitope antigens elicited neutralizing anti-toxin antibodies and anti-adhesin antibodies and suggested that E. coli fimbriae could serve as a platform for the development of broad-spectrum vaccines against ETEC.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20980482      PMCID: PMC3008177          DOI: 10.1128/CVI.00251-10

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  41 in total

Review 1.  Mechanisms in the pathogenesis of diarrhea: a review.

Authors:  H W Moon
Journal:  J Am Vet Med Assoc       Date:  1978-02-15       Impact factor: 1.936

2.  Evaluation of a live avirulent Escherichia coli vaccine for K88+, LT+ enterotoxigenic colibacillosis in weaned pigs.

Authors:  D H Francis; J A Willgohs
Journal:  Am J Vet Res       Date:  1991-07       Impact factor: 1.156

3.  Inhibition of adhesion of Escherichia coli k88ac fimbria to its receptor, intestinal mucin-type glycoproteins, by a monoclonal antibody directed against a variable domain of the fimbria.

Authors:  R Sun; T J Anderson; A K Erickson; E A Nelson; D H Francis
Journal:  Infect Immun       Date:  2000-06       Impact factor: 3.441

Review 4.  Occurrence, distribution, and associations of O and H serogroups, colonization factor antigens, and toxins of enterotoxigenic Escherichia coli.

Authors:  M K Wolf
Journal:  Clin Microbiol Rev       Date:  1997-10       Impact factor: 26.132

Review 5.  Microbial-gut interactions in health and disease. Progress in enteric vaccine development.

Authors:  Ann-Mari Svennerholm; Duncan Steele
Journal:  Best Pract Res Clin Gastroenterol       Date:  2004-04       Impact factor: 3.043

6.  Genetic fusions of heat-labile toxoid (LT) and heat-stable toxin b (STb) of porcine enterotoxigenic Escherichia coli elicit protective anti-LT and anti-STb antibodies.

Authors:  Weiping Zhang; David H Francis
Journal:  Clin Vaccine Immunol       Date:  2010-05-26

7.  Significance of heat-stable and heat-labile enterotoxins in porcine colibacillosis in an additive model for pathogenicity studies.

Authors:  Weiping Zhang; Emil M Berberov; Jessica Freeling; D He; Rodney A Moxley; David H Francis
Journal:  Infect Immun       Date:  2006-06       Impact factor: 3.441

Review 8.  Enterotoxigenic Escherichia coli virulence factors and vaccine approaches.

Authors:  Donata R Sizemore; Kenneth L Roland; Una S Ryan
Journal:  Expert Rev Vaccines       Date:  2004-10       Impact factor: 5.217

9.  Randomized clinical trial assessing the safety and immunogenicity of oral microencapsulated enterotoxigenic Escherichia coli surface antigen 6 with or without heat-labile enterotoxin with mutation R192G.

Authors:  Joyce A Lapa; Stephanie A Sincock; Madhumita Ananthakrishnan; Chad K Porter; Frederick J Cassels; Carl Brinkley; Eric R Hall; John van Hamont; Joseph D Gramling; Colleen M Carpenter; S Baqar; David R Tribble
Journal:  Clin Vaccine Immunol       Date:  2008-06-25

Review 10.  Vaccines for preventing enterotoxigenic Escherichia coli infections in farm animals.

Authors:  H W Moon; T O Bunn
Journal:  Vaccine       Date:  1993       Impact factor: 3.641

View more
  15 in total

Review 1.  Animal Enterotoxigenic Escherichia coli.

Authors:  J Daniel Dubreuil; Richard E Isaacson; Dieter M Schifferli
Journal:  EcoSal Plus       Date:  2016-10

2.  Multiepitope fusion antigen induces broadly protective antibodies that prevent adherence of Escherichia coli strains expressing colonization factor antigen I (CFA/I), CFA/II, and CFA/IV.

Authors:  Xiaosai Ruan; David E Knudsen; Katie M Wollenberg; David A Sack; Weiping Zhang
Journal:  Clin Vaccine Immunol       Date:  2013-12-18

Review 3.  A review on anti-adhesion therapies of bacterial diseases.

Authors:  Arezoo Asadi; Shabnam Razavi; Malihe Talebi; Mehrdad Gholami
Journal:  Infection       Date:  2018-10-01       Impact factor: 3.553

4.  A multiepitope fusion antigen elicits neutralizing antibodies against enterotoxigenic Escherichia coli and homologous bovine viral diarrhea virus in vitro.

Authors:  Emad A Hashish; Chengxian Zhang; Xiaosai Ruan; David E Knudsen; Christopher C Chase; Richard E Isaacson; Guoqiang Zhou; Weiping Zhang
Journal:  Clin Vaccine Immunol       Date:  2013-05-22

5.  Application of a Novel Epitope- and Structure-Based Vaccinology-Assisted Fimbria-Toxin Multiepitope Fusion Antigen of Enterotoxigenic Escherichia coli for Development of Multivalent Vaccines against Porcine Postweaning Diarrhea.

Authors:  Ti Lu; Rodney A Moxley; Weiping Zhang
Journal:  Appl Environ Microbiol       Date:  2020-11-24       Impact factor: 4.792

6.  A tripartite fusion, FaeG-FedF-LT(192)A2:B, of enterotoxigenic Escherichia coli (ETEC) elicits antibodies that neutralize cholera toxin, inhibit adherence of K88 (F4) and F18 fimbriae, and protect pigs against K88ac/heat-labile toxin infection.

Authors:  Xiaosai Ruan; Mei Liu; Thomas A Casey; Weiping Zhang
Journal:  Clin Vaccine Immunol       Date:  2011-08-03

7.  Heat-labile- and heat-stable-toxoid fusions (LTR₁₉₂G-STaP₁₃F) of human enterotoxigenic Escherichia coli elicit neutralizing antitoxin antibodies.

Authors:  Mei Liu; Xiaosai Ruan; Chengxian Zhang; Steve R Lawson; David E Knudsen; James P Nataro; Donald C Robertson; Weiping Zhang
Journal:  Infect Immun       Date:  2011-07-25       Impact factor: 3.441

Review 8.  Current Progress in Developing Subunit Vaccines against Enterotoxigenic Escherichia coli-Associated Diarrhea.

Authors:  Weiping Zhang; David A Sack
Journal:  Clin Vaccine Immunol       Date:  2015-07-01

9.  Porcine Enterotoxigenic Escherichia coli Strains Differ in Their Capacity To Secrete Enterotoxins through Varying YghG Levels.

Authors:  Haixiu Wang; Raquel Sanz Garcia; Eric Cox; Bert Devriendt
Journal:  Appl Environ Microbiol       Date:  2020-11-24       Impact factor: 4.792

10.  Escherichia coli expressing EAST1 toxin did not cause an increase of cAMP or cGMP levels in cells, and no diarrhea in 5-day old gnotobiotic pigs.

Authors:  Xiaosai Ruan; Scott S Crupper; Bruce D Schultz; Donald C Robertson; Weiping Zhang
Journal:  PLoS One       Date:  2012-08-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.